About the Leukemia Session
Leukemia, a form of cancer affecting the blood and bone marrow, remains a significant focus of cancer research due to its complex nature and diverse subtypes. Scientists delve into understanding the genetic mutations and abnormal cell growth underlying leukemia, aiming to develop targeted therapies that minimize side effects and improve outcomes. Advances in precision medicine allow for tailored treatments based on individual genetic profiles, offering hope for more effective and personalized care. Immunotherapy, harnessing the body's immune system to target cancer cells, shows promise in leukemia treatment, with ongoing studies exploring its potential. Additionally, research into novel drug combinations and stem cell transplant techniques continues to push the boundaries of leukemia treatment, striving for better survival rates and quality of life for patients.
Topics Covered in Leukemia
Acute & Chronic Forms
Cytogenetic Risk Groups
Measurable Residual Disease
Kinase Inhibitors
Bispecific T-Cell Engagers
Allogeneic Transplant
Related Scientific Sessions at CIOC 2027
Why Attend the Leukemia Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Leukemia work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Leukemia research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Leukemia track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Leukemia Conference 2027 — FAQs
What is the Leukemia track at CIOC 2027?
The Leukemia track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Leukemia. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Leukemia sessions?
Cancer researchers and clinicians, educators and students with an interest in Leukemia are all welcome — whether presenting or attending.
Can I present my research in the Leukemia track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Leukemia sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Leukemia track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.